Cargando…

Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis

Deregulated immune response and raised inflammation are the cardinal laboratory features in COVID-19 infection reflecting severity of condition. Detection of the markers will help in early diagnosis with timely therapeutic implementation and effective outcome. Observational studies have suggested al...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Suchismita, Nanda, Rachita, Tripathy, Prasanta Kumar, Mangaraj, Manaswini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140259/
https://www.ncbi.nlm.nih.gov/pubmed/34041137
http://dx.doi.org/10.4103/jfmpc.jfmpc_2196_20
_version_ 1783696156268691456
author Panda, Suchismita
Nanda, Rachita
Tripathy, Prasanta Kumar
Mangaraj, Manaswini
author_facet Panda, Suchismita
Nanda, Rachita
Tripathy, Prasanta Kumar
Mangaraj, Manaswini
author_sort Panda, Suchismita
collection PubMed
description Deregulated immune response and raised inflammation are the cardinal laboratory features in COVID-19 infection reflecting severity of condition. Detection of the markers will help in early diagnosis with timely therapeutic implementation and effective outcome. Observational studies have suggested alteration in these parameters with severity of the condition. This systematic review and meta-analysis was conducted to assess the relevance of the fact. Observational studies from databases were scrutinised and 3669 articles were identified. Further screening, based on the inclusion criteria a total of 19 articles with 3115 participants, were reviewed for meta-analysis using random effects model. Any data in median and interquartile range were converted to mean ± SD. There was a significant rise in total leukocyte count, C-reactive protein, ferritin, IL-6, IL-10, procalcitonin in severe cases but absolute lymphocyte count, CD4+ and CD8+ registered a fall in severe cases in comparison to non-severe group. Immune and inflammatory markers are significantly altered and related to severity of manifestation in COVID-19 infection.
format Online
Article
Text
id pubmed-8140259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-81402592021-05-25 Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis Panda, Suchismita Nanda, Rachita Tripathy, Prasanta Kumar Mangaraj, Manaswini J Family Med Prim Care Review Article Deregulated immune response and raised inflammation are the cardinal laboratory features in COVID-19 infection reflecting severity of condition. Detection of the markers will help in early diagnosis with timely therapeutic implementation and effective outcome. Observational studies have suggested alteration in these parameters with severity of the condition. This systematic review and meta-analysis was conducted to assess the relevance of the fact. Observational studies from databases were scrutinised and 3669 articles were identified. Further screening, based on the inclusion criteria a total of 19 articles with 3115 participants, were reviewed for meta-analysis using random effects model. Any data in median and interquartile range were converted to mean ± SD. There was a significant rise in total leukocyte count, C-reactive protein, ferritin, IL-6, IL-10, procalcitonin in severe cases but absolute lymphocyte count, CD4+ and CD8+ registered a fall in severe cases in comparison to non-severe group. Immune and inflammatory markers are significantly altered and related to severity of manifestation in COVID-19 infection. Wolters Kluwer - Medknow 2021-03 2021-04-08 /pmc/articles/PMC8140259/ /pubmed/34041137 http://dx.doi.org/10.4103/jfmpc.jfmpc_2196_20 Text en Copyright: © 2021 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Panda, Suchismita
Nanda, Rachita
Tripathy, Prasanta Kumar
Mangaraj, Manaswini
Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis
title Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis
title_full Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis
title_fullStr Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis
title_full_unstemmed Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis
title_short Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis
title_sort immuno-inflammatory predictors of disease severity in covid-19: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140259/
https://www.ncbi.nlm.nih.gov/pubmed/34041137
http://dx.doi.org/10.4103/jfmpc.jfmpc_2196_20
work_keys_str_mv AT pandasuchismita immunoinflammatorypredictorsofdiseaseseverityincovid19asystematicreviewandmetaanalysis
AT nandarachita immunoinflammatorypredictorsofdiseaseseverityincovid19asystematicreviewandmetaanalysis
AT tripathyprasantakumar immunoinflammatorypredictorsofdiseaseseverityincovid19asystematicreviewandmetaanalysis
AT mangarajmanaswini immunoinflammatorypredictorsofdiseaseseverityincovid19asystematicreviewandmetaanalysis